Kodiak Sciences (KOD) Divestments (2022 - 2023)
Kodiak Sciences (KOD) posted Divestments of -$314000.0 for Q4 2023, down 150.97% on a QoQ basis from $616000.0 in Q4 2022, and down 150.97% year-over-year from $616000.0 in Q4 2022.
Kodiak Sciences (KOD) Divestments (2022 - 2023) Analysis & Trends
Kodiak Sciences' Divestments history runs 2 years deep, the most recent figure standing at -$314000.0 for Q4 2023.
- Quarterly Divestments fell 150.97% year-over-year to -$314000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $302000.0 (changed N/A YoY) and the FY2022 annual result came in at $616000.0, changed N/A from the prior year.
- Divestments was -$314000.0 for Q4 2023 at Kodiak Sciences, down from $616000.0 in the prior quarter.
- Across five years, Divestments topped out at $616000.0 in Q4 2022 and bottomed at -$314000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -314,000.00 |
| Dec 31, 2022 | 616,000.00 |